Mystic Ventures

Mystic Ventures, founded in 2021 and based in Los Angeles, is a venture capital firm focused on the rapidly growing psychedelic medicine and mental health sector. The fund is committed to advancing research and developing innovative treatments using psychedelics to address conditions like depression, anxiety, PTSD, and other mental health issues. Mystic Ventures typically invests in pre-seed and seed-stage companies that are pioneering these therapies. Led by Jeremy Gardner and Brock Pierce, the firm takes a biotech-oriented approach, partnering with scientific research teams and pharmaceutical experts to bring cost-effective, holistic psychedelic solutions to the mainstream. With a rolling fund structure on AngelList, Mystic Ventures is uniquely positioned to offer flexible capital to startups, supporting their long-term growth in the burgeoning field of psychedelic therapeutics. The fund has backed companies like Psylo and Heading Health, among others. By investing in breakthrough treatments that go beyond traditional pharmaceutical approaches, Mystic Ventures aims to reshape how mental health treatments are developed and accessed, while offering investors exposure to this transformative market.